Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

NCC converts client dollars and euros into roubles

6/21/24 MOEX

Launch of the second process line at Vysokoye mine is scheduled for July

6/21/24 UGLD

Number of trips per Whoosh user increased 32%

6/21/24 WUSH

Shareholders of Sberbank approved dividends for 2023

6/21/24 SBER

Yandex Go launched electric bicycle rental in Moscow

6/21/24 YDEX

China's Wison is leaving Russia

6/21/24 NVTK

Government determined the amount of Transneft dividends

6/21/24 TRNFP

Shareholders of Rosseti Centere approved dividends for 2023

6/20/24 MRKC

Moscow Exchange postpones the first pre-IPO transaction

6/20/24 MOEX

Moscow Exchange postpones the first pre-IPO transaction

6/20/24 OTCI